González SR, García GDG, Garcell JR, Hernández-Montiel HL

Idioma: Ingles.
Referencias bibliográficas: 30
Paginas: 190-193
Archivo PDF: 72.93 Kb.

RESUMEN

El retraso en el desarrollo se define como evidencia en 2 o más áreas del desarrollo normal. Los primeros 5 años de vida constituyen un periodo de plasticidad cerebral muy importante, en el cual cambios relevantes tienen lugar en el proceso de desarrollo del sistema nervioso central. Un estimado del 5 al 10% de los niños presenta desórdenes en el desarrollo o comportamiento a nivel mundial. La identificación temprana por instituciones de salud de primer nivel lleva a una referencia temprana para evaluación y tratamiento. La selección de un método de tamizaje en particular constituye una tarea relevante para los médicos, a quienes se les debe estimular para familiarizarce con el uso de estos en orden de tener un mejor pronóstico. En este artículo hacemos una revisión de los test y escalas neurológicas más utilizadas a nivel mundial para la detección oportuna de retrasos en el neurodesarrollo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global development delay: repor t of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003;60:367-80.

2. Krigger KW. Cerebral Palsy: An Overview. Am Fam Physician 2006; 73: 91-101.

3. Paro-Panjan D, Neubauer D, Kodric J, Bratanic B. Amiel-Tison neurological assessment at term age: clinical application, correlation with other methods and outcome at 12 to 15 months. Dev Med Child Neurol 2005; 47: 19-26.

4. Sices L, Feudtner C, McLaughlin J, Drotar D, Williams M. How do primary care physicians manage children with possible developmental delays? A national survey with an experimental design. Pediatrics 2004; 113: 274-82.

5. Sand N, Silverstein M, Glascoe F, Gupta V, Tonniges T, O’Connor K. Pediatricians´ reported practices regarding developmental screening: Do guidelines work? Do they help? Pediatrics 2005; 116: 174-9.

6. Rosenberg S, Zhang D, Robinson C. Prevalence of developmental delays and participation in early Intervention services for young children. Pediatrics 2008;121:1503-09.

7. Dirección General de Información y Evaluación del Desempeño, de la Secretaría de Salud. México 2002.

8. Hermansen M, Hermansen M. Perinatal infections and Cerebral Palsy. Clin Perinatol 2006; 33: 315-33.

9. Miranda del Olmo H, Cardiel-Marmolejo L, Acosta-Gómez Y. A propósito de la historia perinatal en México. Rev Mex Pediatr 2003; 70: 37-40.

10. Liao W, Wen E, Li C, Chang Q, Lv K, Yang W, et al. Predicting neurodevelopmental outcomes for at-risk infants: reliability and predictive validity using a Chinese version of the INFANIB at 3, 7 and 10 months. BMC Pediatr 2012; 12: 72.

11. Wyatt R, Gluckman P, Liu P, Azzopardi L, Ballard R, Edwards A, et al. Determinants of outcomes after head cooling for neonatal encephalopathy; Pediatrics 2007; 119: 912-21.

12. Dixon G, Badawi N, Kurinczuk J, Keogh J, Silburn S, Zubrick S, et al. Early developmental outcomes after newborn encephalopathy. Pediatrics 2002; 109: 26-33.

13. Mwaniki M, Atieno M, Lawn J, Newton C. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012; 379: 445-52.

14. Hix-Small H, Marks K, Squires J, Nickel R. Impact of implementing developmental screening at 12 and 24 months in a pediatric practice. Pediatrics 2007; 120: 381-9.

15. Pérez-Olarte P. Evaluación y manejo del niño con retraso psicomotor Pediatr Integral 2003; 8: 557-66.

16. Rydz D, Srour M, Oskuoi M, Marget N, Shiller M, Birnbaum R, et al. Screening for developmental delay in the setting of a community pediatric clinic: A prospective assessment of parent-report questionnaires. Pediatrics 2006;118:1178-86.

17. Nelson H, Nygren P, Walker M, Panoscha R. Screening for speech and language delay in preschool children: systematic evidence review for the U.S. preventive services task force. Pediatrics 2006; 117: 298-319.

18. Amiel-tison C. Update of the Amiel-Tison neurologic assessment for the term neonate or at 40 weeks corrected age. Pediatr Neurol 2002; 27: 196-212.

19. Leonard C, Piecuch R, Cooper B. Use of the Bayley Infant neurdevelopmental screener with low birth weight Infants. J Pediatr Psychol 2001; 26: 33-40.

20. McCarthy A, Wehby G, Barron S, Aylward G, Castilla E, Javois L, et al. Application of neurodevelopmental screening to a sample of South American infants: the Bayley Infant Neurodevelopmental Screener (BINS). Infant Behav Dev 2012; 35: 280-94.

21. Guedes D, Primi R, Kopelman B. BINS validation-Bayley neurodevelopmental screener in Brazilian preterm children under risk conditions. Infant Behav Dev 2011; 34: 126-35.

22. Msall M. The Bayley-III scale underestimates developmental delay in extremely premature and extremely low birth weight infants. J Pediatr 2010; 157: 863-4.

23. Riou E, Ghosh S, Franceour E, Shevell M. Global developmental delay and its relationship to cognitive skills. Dev Med Child Neurol 2009; 51: 600-06.

24. Provost B, Heimerl S, McClain C, Kim N, Lopez B, Kodituwakku P. Concurrent validity of the Bayley scales of infant development II motor scale and the Peabody developmental motor scales-2 in children with developmental delays. Pediatr Phys Ther 2004; 16: 149-53.

25. Lin K, Chen H, Chen C, Wang T, Wu C, Hsieh Y. Validity, responsiveness, minimal detectable change, and minimal clinically important change of the Pediatric Motor Activity Log in children with cerebral palsy. Res Dev Disabil 2012;33:570-7.

26. Ga H, Kwon J. A comparison of the korean-ages and stages questionnaires and Denver developmental delay screening test. Ann Rehabil Med 2011; 35: 369-74.

27. Filipek P, Accardo P, Ashwal S, Baranek G, Cook E, Dawson G, et al. Practice parameter: Screening and diagnosing of autism: Report of quality standard subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000; 55: 468-79.

28. Wijedasa D. Developmental screening in context: Adaptation and standardization of the Denver Developmental Screening Test-II (DDST-II) for Sri Lankan children. Child Care Health Dev 2012; 38: 889-99.

29. Guadarrama-Celaya F, Otero-Ojeda G, Pliego-Rivero F, Porcayo- Mercado M, Ricardo Garcell J, Perez-Abalo M. Screening of neurodevelopmental delays in four communities of Mexico and Cuba. Public Health Nurs 2012; 29:105-15.

30. Secretaría General del Consejo Nacional de Población (CONAPO); Boletín Nº205/10; 91% De los nacimientos son atendidos por médicos; México, Mayo 2010.